Hasumi Vaccine — Exploring Immune Support to Help Manage Recurrence Risk
Learn about immunotherapy options responsibly. All treatments require physician evaluation; outcomes vary by individual.
Clinical application by Hasumi Cancer Research Institute
Domestic and international statistics since 1948
Hasumi International Research Foundation
Data based on historical statistics and public information, for reference only
About Hasumi Vaccine
The Hasumi Vaccine was proposed and developed by the Hasumi family, with clinical use traceable to 1948. In Japan it is self-pay/private care rather than an insured standard therapy; suitability requires physician evaluation.
This page is for informational purposes only and is not medical advice.
Mechanism of Action
Activating the immune system through four stages
Antigen Recognition
Specific antigens help the immune system identify target cells
Immune Activation
Stimulates immune responses including T cells and NK cells
Targeted Response
Immune cells selectively eliminate abnormal cells
Ongoing Monitoring
Continuous observation of immune response and overall condition
Advantages & Features
Potential benefits that require individual physician assessment
May be combined with standard treatments (potentially enhancing overall care experience)
Relatively low invasiveness with outpatient procedures
Quality of life (QOL) aspects may benefit
Personalized formulation design
May reduce recurrence risk (requires long-term follow-up)
No guaranteed outcomes; individual evaluation required.
Indications / Precautions
Potentially Suitable For
- Post-operative patients seeking to reduce recurrence risk
- Those combining with chemotherapy/radiation/targeted therapy
- Individuals interested in immunotherapy following physician evaluation
- Patients seeking quality of life improvements
Potentially Not Suitable For
- Patients with severe immune system disorders
- During acute infection periods
- Pregnant or breastfeeding women
- Individuals with specific allergies (requires physician assessment)
All suitability must be individually assessed by qualified physicians
Potential Risks / Adverse Reactions
Common injection reactions and precautions
- Redness or discomfort at injection site
- Mild fever
- Fatigue
- Muscle or joint pain
Seek medical attention immediately if symptoms occur. Individual reactions vary; follow physician instructions.
Research / References
Background information on immunotherapy for reference only
Research background information provided for reference; not an endorsement of efficacy
History of Cancer Immunotherapy Development
Journal of Immunotherapy • 2018
The Role of Personalized Vaccines in Cancer Treatment
Nature Reviews • 2020
參考組織 / Reference Organizations
Treatment Process
Complete process from initial consultation to follow-up
Initial Consultation & Assessment
Physician conducts detailed medical history, physical examination, and suitability assessment
Documentation & Testing
Provide pathology reports, imaging data, and undergo necessary tests
Formula Preparation
Customized vaccine formulation based on individual circumstances
Injection & Observation
Administration at clinic with immediate reaction monitoring
Regular Follow-up
Continuous monitoring of immune response and overall condition
Pricing / Insurance
In Japan, Hasumi Vaccine is a self-pay/private care service, generally not covered by health insurance.
Actual costs vary based on individual circumstances, treatment frequency, and formulation.
Get a QuoteFrequently Asked Questions
Contact / Book Consultation
Fill out the form and we'll get back to you soon
Disclaimer / Regulatory Disclosure
⚠️ This page is for informational purposes only and is not medical advice.
- Hasumi Vaccine in Japan is primarily private care/non-insured
- Outcomes vary by individual; no guaranteed efficacy
- All treatments require individual assessment and risk disclosure by qualified physicians
- Information on this website does not establish a doctor-patient relationship
- Consult your primary physician before using any therapy